153 related articles for article (PubMed ID: 15598869)
1. Focus on oxidative stress in the cardiovascular and renal systems.
Wilcox CS; Gutterman D
Am J Physiol Heart Circ Physiol; 2005 Jan; 288(1):H3-6. PubMed ID: 15598869
[No Abstract] [Full Text] [Related]
2. Editorial overview: Cardiovascular and renal: Novel therapeutic strategies and approaches for targeting unmet cardiovascular needs.
Kaczorowski GJ; Pongs O
Curr Opin Pharmacol; 2014 Apr; 15():v-viii. PubMed ID: 24657315
[No Abstract] [Full Text] [Related]
3. The effects of iron dextran on the oxidative stress in cardiovascular tissues of rats with chronic renal failure.
Lim CS; Vaziri ND
Kidney Int; 2004 May; 65(5):1802-9. PubMed ID: 15086920
[TBL] [Abstract][Full Text] [Related]
4. Aliskiren enhances the protective effects of valsartan against cardiovascular and renal injury in endothelial nitric oxide synthase-deficient mice.
Yamamoto E; Kataoka K; Dong YF; Nakamura T; Fukuda M; Tokutomi Y; Matsuba S; Nako H; Nakagata N; Kaneko T; Ogawa H; Kim-Mitsuyama S
Hypertension; 2009 Sep; 54(3):633-8. PubMed ID: 19597038
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular and renal alterations on the nitric oxide pathway in spontaneous hypertension and ageing.
Llorens S; Fernández AP; Nava E
Clin Hemorheol Microcirc; 2007; 37(1-2):149-56. PubMed ID: 17641405
[TBL] [Abstract][Full Text] [Related]
6. Redox Signaling and the Cardiovascular and Skeletal Muscle System.
Gomes AV; Rajasekaran NS; Pi X
Oxid Med Cell Longev; 2015; 2015():849095. PubMed ID: 26523200
[No Abstract] [Full Text] [Related]
7. Transmitting biological information using oxygen: reactive oxygen species as signalling molecules in cardiovascular pathophysiology.
Shah AM; Sauer H
Cardiovasc Res; 2006 Jul; 71(2):191-4. PubMed ID: 16781690
[No Abstract] [Full Text] [Related]
8. Selenoproteins and cardiovascular stress.
Rose AH; Hoffmann PR
Thromb Haemost; 2015 Mar; 113(3):494-504. PubMed ID: 25354851
[TBL] [Abstract][Full Text] [Related]
9. [Redox modification of protein thiols in the regulation of cardiovascular functions].
Yu XX; Gao YS
Sheng Li Ke Xue Jin Zhan; 2012 Feb; 43(1):24-8. PubMed ID: 22582594
[No Abstract] [Full Text] [Related]
10. Urotensin II: a cardiovascular and renal update.
Zoccali C; Mallamaci F
Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):199-204. PubMed ID: 18277155
[TBL] [Abstract][Full Text] [Related]
11. SIRT1 in cardiovascular aging.
Luo XY; Qu SL; Tang ZH; Zhang Y; Liu MH; Peng J; Tang H; Yu KL; Zhang C; Ren Z; Jiang ZS
Clin Chim Acta; 2014 Nov; 437():106-14. PubMed ID: 25063737
[TBL] [Abstract][Full Text] [Related]
12. Nitrate reductase activity of mitochondrial aldehyde dehydrogenase (ALDH-2) as a redox sensor for cardiovascular oxidative stress.
Daiber A; Münzel T
Methods Mol Biol; 2010; 594():43-55. PubMed ID: 20072908
[TBL] [Abstract][Full Text] [Related]
13. Regulation of signal transduction by reactive oxygen species in the cardiovascular system.
Brown DI; Griendling KK
Circ Res; 2015 Jan; 116(3):531-49. PubMed ID: 25634975
[TBL] [Abstract][Full Text] [Related]
14. Role of Nitric Oxide in the Cardiovascular and Renal Systems.
Ahmad A; Dempsey SK; Daneva Z; Azam M; Li N; Li PL; Ritter JK
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30177600
[TBL] [Abstract][Full Text] [Related]
15. Functional importance of T-type voltage-gated calcium channels in the cardiovascular and renal system: news from the world of knockout mice.
Hansen PB
Am J Physiol Regul Integr Comp Physiol; 2015 Feb; 308(4):R227-37. PubMed ID: 25519728
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological approaches to the treatment of oxidative stress-induced cardiovascular dysfunctions.
Zamora PL; Villamena FA
Future Med Chem; 2013 Mar; 5(4):465-78. PubMed ID: 23495692
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II type 2 receptor (AT2R) in renal and cardiovascular disease.
Chow BS; Allen TJ
Clin Sci (Lond); 2016 Aug; 130(15):1307-26. PubMed ID: 27358027
[TBL] [Abstract][Full Text] [Related]
18. Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms.
Dubey RK; Jackson EK
Am J Physiol Renal Physiol; 2001 Mar; 280(3):F365-88. PubMed ID: 11181399
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast Growth Factor-23: A Novel Biomarker for Cardiovascular Disease in Chronic Kidney Disease Patients.
Papagianni A
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2017 Sep; 38(2):19-27. PubMed ID: 28991773
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology of Post Transplant Hypertension in Kidney Transplant: Focus on Calcineurin Inhibitors Induced Oxidative Stress and Renal Sodium Retention and Implications with RhoA/Rho Kinase Pathway.
Calò LA; Ravarotto V; Simioni F; Naso E; Marchini F; Bonfante L; Furian L; Rigotti P
Kidney Blood Press Res; 2017; 42(4):676-685. PubMed ID: 29131070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
